Education
About Us
Working with TipRanks
Follow Us
Astellas Pharma (JP:4503)
OTHER OTC:4503
| Dec 25 | Dec 24 | Dec 23 | Dec 22 | Dec 21 | |
|---|---|---|---|---|---|
| Income Statement | |||||
| Total Revenue | ¥ 1.91T | ¥ 1.60T | ¥ 1.52T | ¥ 1.30T | ¥ 1.25T |
| Gross Profit | ¥ 1.43T | ¥ 1.31T | ¥ 1.23T | ¥ 1.04T | ¥ 1.00T |
| Operating Income | ¥ 255.67B | ¥ 178.07B | ¥ 285.43B | ¥ 220.02B | ¥ 250.90B |
| EBITDA | ¥ 248.30B | ¥ 195.34B | ¥ 240.46B | ¥ 241.03B | ¥ 219.83B |
| Net Income | ¥ 50.75B | ¥ 17.05B | ¥ 98.71B | ¥ 124.09B | ¥ 120.59B |
| Balance Sheet | |||||
| Cash & Short-Term Investments | ¥ 188.37B | ¥ 335.69B | ¥ 376.84B | ¥ 315.99B | ¥ 326.13B |
| Total Assets | ¥ 3.34T | ¥ 3.57T | ¥ 2.46T | ¥ 2.33T | ¥ 2.27T |
| Total Debt | ¥ 831.43B | ¥ 1.01T | ¥ 200.01B | ¥ 212.74B | ¥ 278.26B |
| Net Debt | ¥ 643.05B | ¥ 670.03B | ¥ -176.83B | ¥ -103.24B | ¥ -47.86B |
| Total Liabilities | ¥ 1.83T | ¥ 1.97T | ¥ 948.56B | ¥ 872.09B | ¥ 887.51B |
| Stockholders' Equity | ¥ 1.51T | ¥ 1.60T | ¥ 1.51T | ¥ 1.46T | ¥ 1.39T |
| Cash Flow | |||||
| Free Cash Flow | ¥ 164.61B | ¥ 89.98B | ¥ 239.23B | ¥ 181.00B | ¥ 229.40B |
| Operating Cash Flow | ¥ 201.61B | ¥ 172.47B | ¥ 327.77B | ¥ 257.44B | ¥ 306.84B |
| Investing Cash Flow | ¥ -89.42B | ¥ -845.80B | ¥ -84.50B | ¥ -62.41B | ¥ -81.89B |
| Financing Cash Flow | ¥ -261.37B | ¥ 614.06B | ¥ -195.62B | ¥ -216.30B | ¥ -229.48B |